首頁 > 市場調查報告書 > 醫療設備

醫學影像診斷核子醫學

市場調查報告書

商品編碼

1491570

2024-2028 年全球放射性藥物市場

Global radiopharmaceuticals market 2024-2028

出版日期: 2024年05月17日 | 出版商:

TechNavio | 英文 166 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

放射性藥物市場預計在 2023-2028 年期間成長 62.806 億美元，預測期內複合年成長率為 12.17%。

該報告包括對放射性藥物市場的總體分析、市場規模和預測、趨勢、成長動力、挑戰以及涵蓋約 25 家供應商的供應商分析。

它提供了對當前市場狀況、最新趨勢和促進因素以及整體市場環境的最新分析。該市場的促進因素包括神經系統疾病盛行率上升、癌症病例增加、腫瘤市場投資增加、放射性藥物副作用最小化等。

市場範圍
基準年	2024年
結束年份	2028年
預測期	2024-2028
成長動力	加速度
2024年與前一年同期比較	10.62%
複合年成長率	12.17%
增量	62.806 億美元

這項研究將基於迴旋加速器的放射性藥物生產確定為未來幾年推動放射性藥物市場成長的關鍵因素之一。此外，新型放射性藥物的發現和開發以及新興經濟體醫療保健基礎設施的改善導致了巨大的市場需求。

區域細分
區域比較
北美：2023-2028 年市場規模與預測
歐洲：2023-2028 年市場規模與預測
亞洲：2023-2028年市場規模與預測
世界其他地區：2023-2028 年市場規模與預測
美國：2023-2028 年市場規模與預測
德國：2023-2028年市場規模與預測
英國：2023-2028 年市場規模與預測
加拿大：2023-2028 年市場規模與預測
中國：2023-2028年市場規模及預測
市場機會：依地區狀況

第10章促進因素、挑戰、機會、限制因素

市場促進因素
市場挑戰
促進因素和挑戰的影響
市場機會與限制

第11章競爭格局

概述
競爭格局
混亂的情況
產業風險

第12章競爭分析

公司簡介
公司市場定位
Bayer AG
Bracco Spa
Cardinal Health Inc.
Curium Pharma
Eckert and Ziegler AG
General Electric Co.
IBA Radiopharma Solutions
Jubilant Pharmova Ltd.
Lantheus Holdings Inc.
NorthStar Medical Radioisotopes LLC
Novartis AG
NTP Radioisotopes SOC Ltd.
PharmaLogic Holdings Corp.
Siemens AG
Sotera Health Co.

第13章附錄

簡介目錄圖表

Product Code: IRTNTR43963

The radiopharmaceuticals market is forecasted to grow by USD 6280.6 mn during 2023-2028, accelerating at a CAGR of 12.17% during the forecast period. The report on the radiopharmaceuticals market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the rising incidence of neurological disorders, growing cancer cases rising investment in the oncology market, and minimal side effects of radiopharmaceuticals.

Technavio's radiopharmaceuticals market is segmented as below:

Market Scope
Base Year	2024
End Year	2028
Series Year	2024-2028
Growth Momentum	Accelerate
YOY 2024	10.62%
CAGR	12.17%
Incremental Value	$6280.6mn

BySource

Cyclotrons
Nuclear reactors

ByEnd-user

Diagnostics
Therapeutics

ByGeography

North America
Europe
Asia
Rest of World (ROW)

This study identifies the production of cyclotron-based radiopharmaceuticals as one of the prime reasons driving the radiopharmaceuticals market growth during the next few years. Also, the discovery and development of new radiopharmaceuticals and improvement in healthcare infrastructure in emerging economies will lead to sizable demand in the market.

The report on the radiopharmaceuticals market covers the following areas:

Radiopharmaceuticals market sizing
Radiopharmaceuticals market forecast
Radiopharmaceuticals market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading radiopharmaceuticals market vendors that include Bayer AG, Bracco Spa, Cardinal Health Inc., Curium Pharma, Eckert and Ziegler AG, General Electric Co., IBA Radiopharma Solutions, Jubilant Pharmova Ltd., Lantheus Holdings Inc., Mallinckrodt Plc, NorthStar Medical Radioisotopes LLC, Novartis AG, NTP Radioisotopes SOC Ltd., PharmaLogic Holdings Corp., Positron Corp., Radiomedix Inc., Siemens AG, Sinotau Pharmaceuticals, Sotera Health Co., and Telix Pharmaceuticals Ltd. Also, the radiopharmaceuticals market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

1 Executive Summary

1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market By Geographical Landscape
- Executive Summary - Chart on Market Segmentation by Source
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning

2 Market Landscape

2.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
2.2 Market characteristics
- Market characteristics analysis
2.3 Value chain analysis
- Value Chain Analysis

3 Market Sizing

3.1 Market definition
- Offerings of companies included in the market definition
3.2 Market segment analysis
- Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
- Chart on Global - Market size and forecast 2023-2028 ($ million)
- Data Table on Global - Market size and forecast 2023-2028 ($ million)
- Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

4.1 Global Radiopharmaceuticals Market 2018 - 2022
- Historic Market Size - Data Table on Global Radiopharmaceuticals Market 2018 - 2022 ($ million)
4.2 Source segment analysis 2018 - 2022
- Historic Market Size - Source Segment 2018 - 2022 ($ million)
4.3 End-user segment analysis 2018 - 2022
- Historic Market Size - End-user Segment 2018 - 2022 ($ million)
4.4 Geography segment analysis 2018 - 2022
- Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country segment analysis 2018 - 2022
- Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
- Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
- Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Source

6.1 Market segments
- Chart on Source - Market share 2023-2028 (%)
- Data Table on Source - Market share 2023-2028 (%)
6.2 Comparison by Source
- Chart on Comparison by Source
- Data Table on Comparison by Source
6.3 Cyclotrons - Market size and forecast 2023-2028
- Chart on Cyclotrons - Market size and forecast 2023-2028 ($ million)
- Data Table on Cyclotrons - Market size and forecast 2023-2028 ($ million)
- Chart on Cyclotrons - Year-over-year growth 2023-2028 (%)
- Data Table on Cyclotrons - Year-over-year growth 2023-2028 (%)
6.4 Nuclear reactors - Market size and forecast 2023-2028
- Chart on Nuclear reactors - Market size and forecast 2023-2028 ($ million)
- Data Table on Nuclear reactors - Market size and forecast 2023-2028 ($ million)
- Chart on Nuclear reactors - Year-over-year growth 2023-2028 (%)
- Data Table on Nuclear reactors - Year-over-year growth 2023-2028 (%)
6.5 Market opportunity by Source
- Market opportunity by Source ($ million)
- Data Table on Market opportunity by Source ($ million)

7 Market Segmentation by End-user

7.1 Market segments
- Chart on End-user - Market share 2023-2028 (%)
- Data Table on End-user - Market share 2023-2028 (%)
7.2 Comparison by End-user
- Chart on Comparison by End-user
- Data Table on Comparison by End-user
7.3 Diagnostics - Market size and forecast 2023-2028
- Chart on Diagnostics - Market size and forecast 2023-2028 ($ million)
- Data Table on Diagnostics - Market size and forecast 2023-2028 ($ million)
- Chart on Diagnostics - Year-over-year growth 2023-2028 (%)
- Data Table on Diagnostics - Year-over-year growth 2023-2028 (%)
7.4 Therapeutics - Market size and forecast 2023-2028
- Chart on Therapeutics - Market size and forecast 2023-2028 ($ million)
- Data Table on Therapeutics - Market size and forecast 2023-2028 ($ million)
- Chart on Therapeutics - Year-over-year growth 2023-2028 (%)
- Data Table on Therapeutics - Year-over-year growth 2023-2028 (%)
7.5 Market opportunity by End-user
- Market opportunity by End-user ($ million)
- Data Table on Market opportunity by End-user ($ million)

8 Customer Landscape

8.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
- Chart on Market share By Geographical Landscape 2023-2028 (%)
- Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
- Chart on North America - Market size and forecast 2023-2028 ($ million)
- Data Table on North America - Market size and forecast 2023-2028 ($ million)
- Chart on North America - Year-over-year growth 2023-2028 (%)
- Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
- Chart on Europe - Market size and forecast 2023-2028 ($ million)
- Data Table on Europe - Market size and forecast 2023-2028 ($ million)
- Chart on Europe - Year-over-year growth 2023-2028 (%)
- Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
- Chart on Asia - Market size and forecast 2023-2028 ($ million)
- Data Table on Asia - Market size and forecast 2023-2028 ($ million)
- Chart on Asia - Year-over-year growth 2023-2028 (%)
- Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
- Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
- Chart on US - Market size and forecast 2023-2028 ($ million)
- Data Table on US - Market size and forecast 2023-2028 ($ million)
- Chart on US - Year-over-year growth 2023-2028 (%)
- Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 Germany - Market size and forecast 2023-2028
- Chart on Germany - Market size and forecast 2023-2028 ($ million)
- Data Table on Germany - Market size and forecast 2023-2028 ($ million)
- Chart on Germany - Year-over-year growth 2023-2028 (%)
- Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.9 UK - Market size and forecast 2023-2028
- Chart on UK - Market size and forecast 2023-2028 ($ million)
- Data Table on UK - Market size and forecast 2023-2028 ($ million)
- Chart on UK - Year-over-year growth 2023-2028 (%)
- Data Table on UK - Year-over-year growth 2023-2028 (%)
9.10 Canada - Market size and forecast 2023-2028
- Chart on Canada - Market size and forecast 2023-2028 ($ million)
- Data Table on Canada - Market size and forecast 2023-2028 ($ million)
- Chart on Canada - Year-over-year growth 2023-2028 (%)
- Data Table on Canada - Year-over-year growth 2023-2028 (%)
9.11 China - Market size and forecast 2023-2028
- Chart on China - Market size and forecast 2023-2028 ($ million)
- Data Table on China - Market size and forecast 2023-2028 ($ million)
- Chart on China - Year-over-year growth 2023-2028 (%)
- Data Table on China - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
- Market opportunity By Geographical Landscape ($ million)
- Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Opportunity/Restraints

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2023 and 2028
10.4 Market opportunities/restraints

11 Competitive Landscape

11.1 Overview
11.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
11.3 Landscape disruption
- Overview on factors of disruption
11.4 Industry risks
- Impact of key risks on business

12 Competitive Analysis

12.1 Companies profiled
- Companies covered
12.2 Market positioning of companies
- Matrix on companies position and classification
12.3 Bayer AG
- Bayer AG - Overview
- Bayer AG - Business segments
- Bayer AG - Key news
- Bayer AG - Key offerings
- Bayer AG - Segment focus
12.4 Bracco Spa
- Bracco Spa - Overview
- Bracco Spa - Product / Service
- Bracco Spa - Key offerings
12.5 Cardinal Health Inc.
- Cardinal Health Inc. - Overview
- Cardinal Health Inc. - Business segments
- Cardinal Health Inc. - Key news
- Cardinal Health Inc. - Key offerings
- Cardinal Health Inc. - Segment focus
12.6 Curium Pharma
- Curium Pharma - Overview
- Curium Pharma - Product / Service
- Curium Pharma - Key offerings
12.7 Eckert and Ziegler AG
- Eckert and Ziegler AG - Overview
- Eckert and Ziegler AG - Business segments
- Eckert and Ziegler AG - Key news
- Eckert and Ziegler AG - Key offerings
- Eckert and Ziegler AG - Segment focus
12.8 General Electric Co.
- General Electric Co. - Overview
- General Electric Co. - Business segments
- General Electric Co. - Key news
- General Electric Co. - Key offerings
- General Electric Co. - Segment focus
12.9 IBA Radiopharma Solutions
- IBA Radiopharma Solutions - Overview
- IBA Radiopharma Solutions - Business segments
- IBA Radiopharma Solutions - Key news
- IBA Radiopharma Solutions - Key offerings
- IBA Radiopharma Solutions - Segment focus
12.10 Jubilant Pharmova Ltd.
- Jubilant Pharmova Ltd. - Overview
- Jubilant Pharmova Ltd. - Business segments
- Jubilant Pharmova Ltd. - Key offerings
- Jubilant Pharmova Ltd. - Segment focus
12.11 Lantheus Holdings Inc.
- Lantheus Holdings Inc. - Overview
- Lantheus Holdings Inc. - Business segments
- Lantheus Holdings Inc. - Key offerings
- Lantheus Holdings Inc. - Segment focus
12.12 NorthStar Medical Radioisotopes LLC
- NorthStar Medical Radioisotopes LLC - Overview
- NorthStar Medical Radioisotopes LLC - Product / Service
- NorthStar Medical Radioisotopes LLC - Key offerings
12.13 Novartis AG
- Novartis AG - Overview
- Novartis AG - Business segments
- Novartis AG - Key news
- Novartis AG - Key offerings
- Novartis AG - Segment focus
12.14 NTP Radioisotopes SOC Ltd.
- NTP Radioisotopes SOC Ltd. - Overview
- NTP Radioisotopes SOC Ltd. - Product / Service
- NTP Radioisotopes SOC Ltd. - Key offerings
12.15 PharmaLogic Holdings Corp.
- PharmaLogic Holdings Corp. - Overview
- PharmaLogic Holdings Corp. - Product / Service
- PharmaLogic Holdings Corp. - Key offerings
12.16 Siemens AG
- Siemens AG - Overview
- Siemens AG - Business segments
- Siemens AG - Key news
- Siemens AG - Key offerings
- Siemens AG - Segment focus
12.17 Sotera Health Co.
- Sotera Health Co. - Overview
- Sotera Health Co. - Business segments
- Sotera Health Co. - Key offerings
- Sotera Health Co. - Segment focus

13 Appendix

13.1 Scope of the report
13.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
13.3 Currency conversion rates for US$
- Currency conversion rates for US$
13.4 Research methodology
- Research methodology
13.5 Data procurement
- Information sources
13.6 Data validation
- Data validation
13.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
13.8 Data synthesis
- Data synthesis
13.9 360 degree market analysis
- 360 degree market analysis
13.10 List of abbreviations
- List of abbreviations

簡介目錄圖表

Exhibits:

Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Source
Exhibits6: Executive Summary - Chart on Market Segmentation by End-user
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Company Market Positioning
Exhibits10: Parent Market
Exhibits11: Data Table on - Parent Market
Exhibits12: Market characteristics analysis
Exhibits13: Value Chain Analysis
Exhibits14: Offerings of companies included in the market definition
Exhibits15: Market segments
Exhibits16: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits17: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits18: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits19: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits20: Historic Market Size - Data Table on Global Radiopharmaceuticals Market 2018 - 2022 ($ million)
Exhibits21: Historic Market Size - Source Segment 2018 - 2022 ($ million)
Exhibits22: Historic Market Size - End-user Segment 2018 - 2022 ($ million)
Exhibits23: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits24: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits25: Five forces analysis - Comparison between 2023 and 2028
Exhibits26: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits28: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits29: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits30: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits31: Chart on Market condition - Five forces 2023 and 2028
Exhibits32: Chart on Source - Market share 2023-2028 (%)
Exhibits33: Data Table on Source - Market share 2023-2028 (%)
Exhibits34: Chart on Comparison by Source
Exhibits35: Data Table on Comparison by Source
Exhibits36: Chart on Cyclotrons - Market size and forecast 2023-2028 ($ million)
Exhibits37: Data Table on Cyclotrons - Market size and forecast 2023-2028 ($ million)
Exhibits38: Chart on Cyclotrons - Year-over-year growth 2023-2028 (%)
Exhibits39: Data Table on Cyclotrons - Year-over-year growth 2023-2028 (%)
Exhibits40: Chart on Nuclear reactors - Market size and forecast 2023-2028 ($ million)
Exhibits41: Data Table on Nuclear reactors - Market size and forecast 2023-2028 ($ million)
Exhibits42: Chart on Nuclear reactors - Year-over-year growth 2023-2028 (%)
Exhibits43: Data Table on Nuclear reactors - Year-over-year growth 2023-2028 (%)
Exhibits44: Market opportunity by Source ($ million)
Exhibits45: Data Table on Market opportunity by Source ($ million)
Exhibits46: Chart on End-user - Market share 2023-2028 (%)
Exhibits47: Data Table on End-user - Market share 2023-2028 (%)
Exhibits48: Chart on Comparison by End-user
Exhibits49: Data Table on Comparison by End-user
Exhibits50: Chart on Diagnostics - Market size and forecast 2023-2028 ($ million)
Exhibits51: Data Table on Diagnostics - Market size and forecast 2023-2028 ($ million)
Exhibits52: Chart on Diagnostics - Year-over-year growth 2023-2028 (%)
Exhibits53: Data Table on Diagnostics - Year-over-year growth 2023-2028 (%)
Exhibits54: Chart on Therapeutics - Market size and forecast 2023-2028 ($ million)
Exhibits55: Data Table on Therapeutics - Market size and forecast 2023-2028 ($ million)
Exhibits56: Chart on Therapeutics - Year-over-year growth 2023-2028 (%)
Exhibits57: Data Table on Therapeutics - Year-over-year growth 2023-2028 (%)
Exhibits58: Market opportunity by End-user ($ million)
Exhibits59: Data Table on Market opportunity by End-user ($ million)
Exhibits60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits61: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits62: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits63: Chart on Geographic comparison
Exhibits64: Data Table on Geographic comparison
Exhibits65: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits66: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits67: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits68: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits69: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits70: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits71: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits72: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits73: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits74: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits75: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits76: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits77: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits78: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits79: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits80: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits81: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits82: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits83: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits84: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits85: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits86: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits87: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits88: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits89: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits90: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits91: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits92: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits93: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits94: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits95: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits96: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits97: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits98: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits99: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits100: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits101: Market opportunity By Geographical Landscape ($ million)
Exhibits102: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits103: Impact of drivers and challenges in 2023 and 2028
Exhibits104: Overview on criticality of inputs and factors of differentiation
Exhibits105: Overview on factors of disruption
Exhibits106: Impact of key risks on business
Exhibits107: Companies covered
Exhibits108: Matrix on companies position and classification
Exhibits109: Bayer AG - Overview
Exhibits110: Bayer AG - Business segments
Exhibits111: Bayer AG - Key news
Exhibits112: Bayer AG - Key offerings
Exhibits113: Bayer AG - Segment focus
Exhibits114: Bracco Spa - Overview
Exhibits115: Bracco Spa - Product / Service
Exhibits116: Bracco Spa - Key offerings
Exhibits117: Cardinal Health Inc. - Overview
Exhibits118: Cardinal Health Inc. - Business segments
Exhibits119: Cardinal Health Inc. - Key news
Exhibits120: Cardinal Health Inc. - Key offerings
Exhibits121: Cardinal Health Inc. - Segment focus
Exhibits122: Curium Pharma - Overview
Exhibits123: Curium Pharma - Product / Service
Exhibits124: Curium Pharma - Key offerings
Exhibits125: Eckert and Ziegler AG - Overview
Exhibits126: Eckert and Ziegler AG - Business segments
Exhibits127: Eckert and Ziegler AG - Key news
Exhibits128: Eckert and Ziegler AG - Key offerings
Exhibits129: Eckert and Ziegler AG - Segment focus
Exhibits130: General Electric Co. - Overview
Exhibits131: General Electric Co. - Business segments
Exhibits132: General Electric Co. - Key news
Exhibits133: General Electric Co. - Key offerings
Exhibits134: General Electric Co. - Segment focus
Exhibits135: IBA Radiopharma Solutions - Overview
Exhibits136: IBA Radiopharma Solutions - Business segments
Exhibits137: IBA Radiopharma Solutions - Key news
Exhibits138: IBA Radiopharma Solutions - Key offerings
Exhibits139: IBA Radiopharma Solutions - Segment focus
Exhibits140: Jubilant Pharmova Ltd. - Overview
Exhibits141: Jubilant Pharmova Ltd. - Business segments
Exhibits142: Jubilant Pharmova Ltd. - Key offerings
Exhibits143: Jubilant Pharmova Ltd. - Segment focus
Exhibits144: Lantheus Holdings Inc. - Overview
Exhibits145: Lantheus Holdings Inc. - Business segments
Exhibits146: Lantheus Holdings Inc. - Key offerings
Exhibits147: Lantheus Holdings Inc. - Segment focus
Exhibits148: NorthStar Medical Radioisotopes LLC - Overview
Exhibits149: NorthStar Medical Radioisotopes LLC - Product / Service
Exhibits150: NorthStar Medical Radioisotopes LLC - Key offerings
Exhibits151: Novartis AG - Overview
Exhibits152: Novartis AG - Business segments
Exhibits153: Novartis AG - Key news
Exhibits154: Novartis AG - Key offerings
Exhibits155: Novartis AG - Segment focus
Exhibits156: NTP Radioisotopes SOC Ltd. - Overview
Exhibits157: NTP Radioisotopes SOC Ltd. - Product / Service
Exhibits158: NTP Radioisotopes SOC Ltd. - Key offerings
Exhibits159: PharmaLogic Holdings Corp. - Overview
Exhibits160: PharmaLogic Holdings Corp. - Product / Service
Exhibits161: PharmaLogic Holdings Corp. - Key offerings
Exhibits162: Siemens AG - Overview
Exhibits163: Siemens AG - Business segments
Exhibits164: Siemens AG - Key news
Exhibits165: Siemens AG - Key offerings
Exhibits166: Siemens AG - Segment focus
Exhibits167: Sotera Health Co. - Overview
Exhibits168: Sotera Health Co. - Business segments
Exhibits169: Sotera Health Co. - Key offerings
Exhibits170: Sotera Health Co. - Segment focus
Exhibits171: Inclusions checklist
Exhibits172: Exclusions checklist
Exhibits173: Currency conversion rates for US$
Exhibits174: Research methodology
Exhibits175: Information sources
Exhibits176: Data validation
Exhibits177: Validation techniques employed for market sizing
Exhibits178: Data synthesis
Exhibits179: 360 degree market analysis
Exhibits180: List of abbreviations